炎症严重程度,而不是呼吸衰竭,与高海拔重症监护室ARDS患者的死亡率密切相关
Daniel Molano-Franco1,2,3,4,5, Joan Ramon Masclans Enviz6,7, Antonio Viruez-Soto1,2,3,8
1High Altitude Intensive Care Medicine International Group (GIMIA), La Paz, Bolivia.
Frontiers in physiology
|January 30, 2025
概括
在重症监护室 (ICU) 的高海拔急性呼吸困扰综合征 (ARDS) 患者通过监测炎症标志物,可能有更好的生存率. 这种方法可能比只关注低氧条件下的呼吸衰竭更有效.
科学领域:
- 关键护理医学 关键护理医学
- 高海拔地区的生理学
- 呼吸系统医学 呼吸系统医学
背景情况:
- 高海拔城市 (2500米以上) 报告了急性呼吸困扰综合征 (ARDS) 的重症监护室 (ICU) 患者的50%以上死亡率.
- 现有的医疗方案往往忽视了高海拔居民对缺氧的独特生理适应.
- 这种差距有助于在高海拔地区的ARDS病例中取得糟糕的结果.
研究的目的:
- 分析来自高海拔重症监护室的人口,临床,性别和临床前数据.
- 在这些特定环境中确定ARDS相关死亡率的关键临床预测因素.
- 为了解决ARDS的高度特定医疗协议的缺乏.
主要方法:
- 在ICU入院24小时内对70名成年ARDS患者的评估.
- 收集综合数据:人口统计,临床特征,生命体征,呼吸和心肺呼吸系统参数,血液细胞计数,炎症标志物,严重性得分和并发症.
- 应用先进的统计分析,包括多变量逻辑回归和主要组件分析.
主要成果:
- 监测炎症标志物似乎比专注于呼吸衰竭标志物更有利于高海拔ICU中ARDS生存.
- 在海拔2650米和4150米之间没有观察到临床结果的显著差异.
- 在男性和女性患者之间没有发现临床结果的显著差异.
结论:
- 在高海拔的ICU中,ARDS患者的存活率与管理炎症反应更为密切相关,而不是仅仅关注呼吸系统参数.
- 炎症标志物监测显示,在高海拔环境中改善ARDS生存率是有前途的.
- 建议进行进一步的大规模研究,以确认炎症标志物监测对生存结果的影响.
相关概念视频
Acute Respiratory Failure-IV
120
Respiratory failure can manifest suddenly or gradually, characterized by a rapid decline in PaO2 and a rapid rise in PaCO2. This situation indicates a severe respiratory problem that may quickly become a life-threatening emergency. One of the early signs of hypoxemic Acute Respiratory Failure (ARF) is a change in mental status due to the brain's sensitivity to oxygen levels and changes in acid-base balance. Symptoms such as restlessness, confusion, and agitation suggest inadequate oxygen...
120
Acute Respiratory Failure-I
162
Acute respiratory failure is a condition characterized by the inability of the lungs to perform their primary function: gas exchange. This failure leads to insufficient oxygen levels (hypoxemia) in the blood, elevated carbon dioxide levels (hypercapnia), or both, causing critical impairment in organ function.
Definition: It is defined by specific criteria based on blood gas measurements. Hypoxemia happens when the partial pressure of oxygen (PaO2) falls below 60 mmHg. At the same time,...
Definition: It is defined by specific criteria based on blood gas measurements. Hypoxemia happens when the partial pressure of oxygen (PaO2) falls below 60 mmHg. At the same time,...
162
Acute Respiratory Failure-II
166
Type I Respiratory Failure, or hypoxemic respiratory failure, occurs when the partial pressure of oxygen (PaO2) in arterial blood falls below 60 mmHg while breathing room air without a corresponding increase in arterial carbon dioxide levels (PaCO2). This condition highlights a significant impairment in the lungs' capacity to oxygenate the blood.
The underlying physiological abnormalities that contribute to hypoxemic respiratory failure include:
The underlying physiological abnormalities that contribute to hypoxemic respiratory failure include:
166
Acute Respiratory Failure-III
153
Hypercapnic respiratory failure, also known as Type 2 or ventilatory respiratory failure, is a severe condition characterized by the body's inability to effectively remove carbon dioxide (CO2) from the bloodstream. It leads to an arterial CO2 pressure (PaCO2) exceeding 45 mmHg and a blood pH above 7.35. This situation indicates that the body's ventilatory demand, or the ventilation needed to maintain normal PaCO2 levels, surpasses its supply or the maximum gas flow achievable without...
153
Asthma-III: Symptoms and Complications
2.5K
Asthma, a common chronic respiratory condition, is classified considering the frequency and severity of symptoms alongside lung function impairment. Understanding this classification is essential for appropriate treatment and management. Here's a detailed look at the classification of asthma and its clinical features and complications:
Classification of Asthma
Classification of Asthma
2.5K
Acute Respiratory Failure-V
122
The treatment for acute respiratory failure varies based on factors like the underlying cause, overall health, and severity. A collaborative healthcare team is essential for early detection, often through arterial blood gas analysis. Identifying the cause is the primary goal, with treatment strategies adjusted for ventilation/perfusion (V/Q) mismatch, shunting, or diffusion impairment.
Ensure that patients are monitored continuously for their response to therapy, including changes in...
Ensure that patients are monitored continuously for their response to therapy, including changes in...
122


